Regulatory
Brokers Asked to Suspend Margin Loans for IBP Shares
Brokers and merchant bankers were asked to stop providing margin-loan facilities for purchases of IBP shares.
IBPPharmaceuticals & Chemicals
Follow the latest news and corporate disclosures of Indo-Bangla Pharmaceuticals Limited (DSE: IBP), including board meetings, quarterly financial results, dividend decisions, record dates, AGM notices and regulatory updates.
Brokers and merchant bankers were asked to stop providing margin-loan facilities for purchases of IBP shares.
IBP moved from N category to A category effective 9 January 2019 after reporting disbursement of its approved cash dividend.
IBP published a corporate disclosure on 8 January 2019. Read the full announcement for details.
IBP published a corporate disclosure on 27 November 2018. Read the full announcement for details.
IBP published a corporate disclosure on 15 November 2018. Read the full announcement for details.
IBP published a corporate disclosure on 15 November 2018. Read the full announcement for details.
IBP published a corporate disclosure on 14 November 2018. Read the full announcement for details.
IBP published a corporate disclosure on 12 November 2018. Read the full announcement for details.
IBP will hold a board meeting on 14 November 2018 at 3:30 PM.
IBP published a corporate disclosure on 28 October 2018. Read the full announcement for details.